Scherm­afbeelding 2025 01 23 om 13.38.53

Nova biomedical

The Most Clinically Advanced Critical Care Test Menu Now Includes Creat•eGFR•BUN•ePV•iMg•MCHC

Scherm­afbeelding 2025 01 23 om 13.37.32

Pittcon

UNLOCKING INNOVATION TOGETHER: ADVANCING POINT OF CARE TESTING

Scherm­afbeelding 2025 01 23 om 13.39.09

The Intelligent Analyzer GEM

GEM Premier 5000 blood gas testing system provides automated quality assurance with every whole-blood* sample. Now with next-generation Intelligent Quality Management (iQM2), featuring IntraSpect™ technology, potential errors are detected not only before and after, but also during sample analysis, along with real-time correction and documentation.

AdobeStock 1133655972

Diagnosis and management of subarachnoid hemorrhage

If a patient has a suspected subarachnoid brain hemorrhage (SAH), time is of the essence. CLI chatted to Dr Suneesh Thilak (New Cross Hospital, Wolverhampton, UK) to find out about the role that imaging plays in diagnosis, securement and subsequent patient management of SAH.

AdobeStock 586346505

Technological advances allow use of mid-infrared spectroscopy for therapeutic drug monitoring

Therapeutic drug monitoring is used for a number of reasons. The usual techniques include immunoassay and mass spectrometry, both of which have limitations. CLI chatted to Dr Pin Dong (University of York, York, UK) to discuss the potential for Fourier transform infrared spectroscopy to bridge the gap and provide high specificity measurements with a fast […]

revvity assay

Revvity’s new automated free testosterone assay receives FDA clearance

Revvity Inc has announced FDA 510(k) clearance for EUROIMMUN’s automated chemilumin-escence immunoassay (ChLIA) for direct quantitative measurement of free testosterone. The assay, which runs on the company’s iSYS and i10 platforms, represents the first FDA-cleared automated direct measurement method for free testosterone in human serum or plasma.

sapiosciences

Sapio Sciences expands laboratory informatics capabilities

Laboratory software provider Sapio Sciences has announced significant updates to its informatics platform, enhancing functionality across chemistry, immunogenicity, GMP workflows and molecular biology. Release 24.12 introduces automated validation tools and refined chemistry representation capabilities, aimed at improving laboratory efficiency and data management.

thermofisher Magmax

Thermo Fisher unveils DNA/RNA extraction kit for haematological cancer research

A new sequential DNA/RNA isolation kit has been launched by Thermo Fisher Scientific, designed to streamline genomic analysis workflows in haematological cancer research. The MagMAX Sequential DNA/RNA kit enables concurrent extraction of DNA and RNA from a single sample, potentially accelerating research into blood-based malignancies.

SAA CLI 250121

Serum Amyloid A (SAA) nephelometric and turbidimetric assays

TRIMERO Diagnostics offers assays for testing Serum Amyloid A (SAA) on Beckman Coulter’s IMMAGE® Immunochemical Systems and Clinical Chemistry Analyzers.

JJ depression

Johnson & Johnson acquires lumateperone developer in £14.6bn deal

Johnson & Johnson (J&J) has announced the acquisition of Intra-Cellular Therapies for $14.6 billion, marking a significant expansion of its neuroscience portfolio. The deal centres on CAPLYTA (lumateperone), a novel antipsychotic with a distinctive pharmacological profile characterised by high serotonin 5-HT2A receptor occupancy combined with lower dopamine D2 receptor binding at therapeutic doses.